News Archive

November 2018

• Media ReleaseNov 20, 2018

  Novartis rises to second place in 2018 Access to Medicine Index

  Company leads the industry in access-to-medicine management thanks to long- term commitment, as well as ongoing innovation in access to healthcare Novartis moves up one position from number 3 in…
• Media ReleaseNov 20, 2018

  Sandoz and Pear Therapeutics announce launch of reSET® for treatment of patients with Substance Use Disorder

  reSET® is the first and only FDA-authorized prescription digital therapeutic for Substance Use Disorder (SUD) Adding reSET to outpatient therapy significantly improved abstinence in substances of…
• Media ReleaseNov 16, 2018

  FDA approves Novartis drug Promacta® for first-line SAA and grants Breakthrough Therapy designation for additional new indication

  Promacta receives FDA approval for first-line treatment of severe aplastic anemia (SAA) and Breakthrough Therapy designation for low platelet counts in people exposed to radiation  Approval…
• Media ReleaseNov 16, 2018

  Novartis receives positive CHMP opinion to expand Kisqali® combination therapy to all women with HR+/HER2- locally advanced or metastatic breast cancer

  Kisqali is the CDK4/6 inhibitor with the largest body of first-line evidence demonstrating consistent, superior and sustained efficacy vs. endocrine therapy alone[1]   CHMP opinion is…
• Key ReleaseNov 13, 2018

  Alcon files initial Form 20-F registration statement with SEC for proposed spinoff; plans investor days in New York and London

  Basel, November 13, 2018 - Novartis today announced that Alcon has filed an initial Form 20-F registration statement with the US Securities and Exchange Commission (SEC) in relation to the previously…
• 
  StoryNov 12, 2018 Discovery

  Artificial intelligence decodes cancer pathology images without image gallery

  Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.

• 
  StoryNov 12, 2018 Discovery

  Artificial intelligence decodes cancer pathology images

  Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.

• Media ReleaseNov 11, 2018

  New Novartis study supports Entresto as foundational HFrEF therapy and in-hospital initiation in appropriate stabilized heart failure patients

  Entresto® (sacubitril/valsartan) outperformed commonly used heart failure medicine enalapril in landmark study; delivered significantly greater and more rapid reductions in an established biomarker…
• 
  StoryNov 05, 2018 From Our Labs

  Women in Science: Wendy Winckler

  Meet Wendy Winckler, Executive Director of Oncology Research at Novartis.

• 
  StoryNov 05, 2018 From Our Labs

  Women in Science: Jennifer Allport-Anderson

  Cardiovascular researcher Jennifer Allport-Anderson describes the personal qualities and decisions that have made her a successful leader.

• 
  StoryNov 05, 2018 From Our Labs

  Women in Science: Jean Silveri

  Jean Silveri shares key insights from her legal career.

• 
  StoryNov 05, 2018 From Our Labs

  Women in Science: Cyndy Grosskreutz

  Physician-scientist Cyndy Grosskreutz explains why she transitioned from academia to industry.